AllSight
Companies · MGTX · Biological Products, (No Diagnostic Substances)

MeiraGTx Holdings plc (MGTX)

MeiraGTx Holdings plc (MGTX) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

MeiraGTx Holdings plc (MGTX) stock — financials & valuation

Key numbers for MeiraGTx Holdings plc (MGTX): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 66/100 — a percentile rank of MeiraGTx Holdings plc’s fundamentals against Manufacturing peers, weakest on valuation. A quality ranking, not a price prediction.

Market cap$1.0B
P / E13.0×
P / S2.6×
EV / EBITDA5.1×
Gross margin98.2%
Operating margin46.3%
Net margin19.9%
Return on equity36.6%
ROIC92.1%
Revenue growth948.3%
Debt / equity0.6×
Dividend yield0.0%

Is MeiraGTx Holdings plc overvalued? P/S looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.

Independent of the events above — derived from MeiraGTx Holdings plc’s own financial statements and shown as context, never as advice.

Aug 13, 2026Beat
The $1.71 EPS headline is real—but mostly a deal-accounting artifact
Related companies in Biological Products, (No Diagnostic Substances)
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact